
    
      Patients with radiologically-assessed locally advanced non-metastatic colorectal cancer will
      receive the following treatment before surgery:

      Colon cancers:

      One cycle of CAPEOX chemotherapy Two cycles of Pembrolizumab on Day 1 (concurrent with CAPEOX
      chemotherapy) and Day 22

      Rectal cancers:

      Following completion of chemo-radiotherapy with 5-fluorouracil (5-FU)/ capecitabine, patients
      will receive 2 cycles of Pembrolizumab given 3 weeks apart

      Pre-operative biopsy and surgical samples as well as blood will be collected for
      translational studies.
    
  